Immunomodulatory Effect of Propolis Extract on Population of IL-10 and TGF-β Expression in CD4+CD25+ Regulatory T Cells in DMBA-induced Breast Cancer in Female Sprague-Dawley Rats
Journal Title: Turkish Journal of Immunology - Year 2017, Vol 5, Issue 3
Abstract
Introduction: The aim of this study was to investigate the effect of propolis extract to the population of regulatory T cells (CD4+CD25+FoxP3+) expressing IL-10 and TGF-β in vivo (DMBA-induced breast cancer in Female Sprague-Dawley Rats). Materials and Methods: Thirty virgin female Sprague-Dawley rats, aged 45–50 days-old were injected subcutaneously with 2x10 mg of 7.12-dimethylbenz(a)anthracene (DMBA) for one-week intervals. A week later each rat was administered orally with 5 mg DMBA. Ten rats without DMBA served as negative control. To ensure the development of breast cancer before starting treatment, at week 8, five rats that received DMBA and five negative controls were randomly selected and euthanized. Their breast tissues were then dissected for histological analysis by hematoxylin-eosin staining. Breast ductal cell morphological changes were apparent in DMBA-treated rats. The remaining rats were divided into 5 groups (6 rats per group). Group I served as a negative control, and Groups II–V were animals treated with DMBA, where Group II served as positive control, and Group III, IV, and V were animals treated with ethanolic extract of propolis (EEP) at doses of 50, 100, and 200 mg/kg body weight (BW), respectively, for 4 weeks. The animals were sacrificed by cervical decapitation. Breast and spleen tissues were subjected to histological and flow cytometric analysis respectively. Results: Statistical analysis by linear regression showed a significant decline in the relative number of CD4+CD25+FoxP3+ regulatory T cells expressing IL-10 or TGF-β after treatments with propolis extracts. Conclusion: In summary, propolis may act as immunomodulatory agent that can be useful for curing cancer patients. Keywords: Breast cancer, propolis, regulatory T cells, IL-10, TGF-β, in vivo
Authors and Affiliations
Zauhani Kusnul, Pudji Rahayu, Muhaimin Rifa’i, Edi Widjajanto
Keywords
Related Articles
- EP ID EP449921
- DOI 10.25002/tji.2017.573
- Views 102
- Downloads 0
Prevalence of HLA-DQ*02 and HLA-DQ*08 in Patients with Celiac Disease in Eastern Anatolia and the Diagnostic Role of HLA-DQ*02 and HLA-DQ*08 Genotyping
Introducton: Celiac disease (CD) is diagnosed with serological tests and small bowel biopsy. There is a strong link between CD and human leukocyte antigens (HLA). In this study, we aimed to determine the role of HLA alle...
Interleukin-2 Immunotherapy for Advanced Cancer
Interleukin-2 (IL-2) was the first approved immunotherapy to show efficacy in advanced cancer. 13–20% of patients with metastatic renal cell carcinoma and metastatic melanoma receiving high-dose IL-2 treatment showed obj...
Increased Expression of Lymphocyte Activation Gene-3 by Regulatory T Cells in Multiple Sclerosis Patients with Fingolimod Treatment
Introduction: Multiple sclerosis (MS) is associated with the failure of peripheral tolerance to self-antigens. Regulatory T cells (Tregs) play a pivotal role in regulating the immune system and inhibiting development of...
Immunomodulatory Effect of Propolis Extract on Population of IL-10 and TGF-β Expression in CD4+CD25+ Regulatory T Cells in DMBA-induced Breast Cancer in Female Sprague-Dawley Rats
Introduction: The aim of this study was to investigate the effect of propolis extract to the population of regulatory T cells (CD4+CD25+FoxP3+) expressing IL-10 and TGF-β in vivo (DMBA-induced breast cancer in Female Spr...
Anti-inflammatory and Anti-atherogenic Effects of Lactobacillus plantarum in Hypercholesterolemic Mice
Introduction: Cardiovascular diseases are the most prevalent cause of human morbidity and mortality worldwide and atherosclerosis is the main underlying cause of it. Probiotics comprise live microorganisms which have bee...